Korean J Urol.  2009 Nov;50(11):1089-1094.

Initial Experiences with a New 120 W Greenlight(TM) High-Power System for Photoselective Vaporization of the Prostate for the Treatment of Benign Prostatic Hyperplasia in Korea

• Ko DW
• Jeong BC
• Son H

Abstract

PURPOSE
After successful launches of a 120 W high-power system for photoselective vaporization of the prostate (HPS-PVP), several studies in the United States and Europe have reported good short-term data. Here we report the initial efficacy and side effects of the 120 W HPS-PVP in Korea. MATERIALS AND METHODS: Between January 2008 and January 2009, we performed a retrospective clinical analysis of 133 patients treated by HPS-PVP.
RESULTS
The mean age at surgery was 68.4+/-8.0 years. The mean prostate size was 44.2+/-22.6 ml. The mean operation time was 58.9+/-33.5 minutes, and the mean total applied energy was 103,108+/-74,362 J. The mean duration of catheterization was 21.5+/-10.8 hours. The blood loss was minimal, and there were no transfusions. The baseline mean peak urinary flow rate (Qmax) was 10.4+/-5.0 ml/s, mean postvoid residual volume (PVR) was 77+/-91.3 ml, the mean International Prostate Symptom Score (IPSS) was 20.7+/-9.0, and the mean quality of life (QoL) score was 4.2+/-1.3. At 6 months, Qmax was 17.5+/-9.9 ml/sec, PVR was 49.0+/-56.0 ml, the IPSS was 8.0+/-9.0, and the QoL score was 1.6+/-1.5. During the first postoperative month, irritative urinary symptoms were reported in 18 cases, urge incontinence in 7, mild hematuria in 5, urinary tract infection in 2, and temporary recatheterization in 13.
CONCLUSIONS
The new 120 W HPS-PVP showed good short-term safety and efficacy for the treatment of Korean patients with benign prostatic hyperplasia.

Keyword

Prostatic hyperplasia; Vaporization; Lasers

MeSH Terms

Catheterization
Catheters
Europe
Hematuria
Humans
Korea
Prostate
Prostatic Hyperplasia
Quality of Life
Residual Volume
Retrospective Studies
United States
Urinary Incontinence, Urge
Urinary Tract Infections
Volatilization

Reference

1. Yu X, Elliott SP, Wilt TJ, McBean AM. Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies. J Urol. 2008. 180:241–245.

2. Malek RS, Kuntzman RS, Barrett DM. High power potassium-titanyl-phosphate laser vaporization prostatectomy. J Urol. 2000. 163:1730–1733.

3. Malek RS, Kuntzman RS, Barrett DM. Photoselective potassium-titanyl-phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes. J Urol. 2005. 174:1344–1348.

4. Hwang CH, Cho CK, Lee YK, Hong SJ. Comparative analysis of short-term efficacy and complication of photoselective vaporization for benign prostatic hyperplasia which was classified by prostate size. Korean J Urol. 2007. 48:826–831.

5. Park JS, Min GE, You CH, Hong B, Kim CS, Ahn H, et al. Comparison of treatment outcomes between photoselective vaporization and transurethral resection of the prostate for benign prostatic hyperplasia. Korean J Urol. 2007. 48:297–303.

6. Wong C, Araki M, Tonkin JB. High-power potassium-titanyl-phosphate or lithium triboride laser photoselective vaporization prostatectomy for benign prostatic hyperplasia: a systematic approach. J Endourol. 2007. 21:1141–1144.

7. Spaliviero M, Araki M, Page JB, Wong C. Catheter-free 120W lithium triborate (LBO) laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH). Lasers Surg Med. 2008. 40:529–534.

8. Spaliviero M, Araki M, Culkin DJ, Wong C. Incidence, management, and prevention of perioperative complications of GreenLight HPS laser photoselective vaporization prostatectomy: experience in the first 70 patients. J Endourol. 2009. 23:495–502.

9. Paick JS, Um JM, Kwak C, Kim SW, Ku JH. Influence of bladder contractility on short-term outcomes of high-power potassium-titanyl-phosphate photoselective vaporization of the prostate. Urology. 2007. 69:859–863.

10. Blute ML, Tomera KM, Hellerstein DK, McKiel CF Jr, Lynch JH, Regan JB, et al. Transurethral microwave thermotherapy for management of benign prostatic hyperplasia: results of the United States Prostatron Cooperative Study. J Urol. 1993. 150:1591–1596.

11. Kaplan SA, Te AE. Transurethral electrovaporization of the prostate: a novel method for treating men with benign prostatic hyperplasia. Urology. 1995. 45:566–572.

12. Hai MA, Malek RS. Photoselective vaporization of the prostate: initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia. J Endourol. 2003. 17:93–96.

13. Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA, et al. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol. 2004. 172:1404–1408.

14. Bachmann A, Schürch L, Ruszat R, Wyler SF, Seifert HH, Müller A, et al. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol. 2005. 48:965–971.

15. Alivizatos G, Skolarikos A, Chalikopoulos D, Papachristou C, Sopilidis O, Dellis A, et al. Transurethral photoselective vaporization versus transvesical open enucleation for prostatic adenomas >80 ml: 12-mo results of a randomized prospective study. Eur Urol. 2008. 54:427–437.

16. Ruszat R, Seitz M, Wyler SF, Abe C, Rieken M, Reich O, et al. GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. Eur Urol. 2008. 54:893–901.

17. Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention. Eur Urol. 2006. 50:969–979.

18. Ruszat R, Seitz M, Wyler SF, Müller G, Rieken M, Bonkat G, et al. Prospective single-centre comparison of 120-W diode-pumped solid-state high-intensity system laser vaporization of the prostate and 200-W high-intensive diode-laser ablation of the prostate for treating benign prostatic hyperplasia. BJU Int. 2009. 104:820–825.

19. Spaliviero M, Araki M, Wong C. Short-term outcomes of Greenlight HPS laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH). J Endourol. 2008. 22:2341–2347.

20. Briganti A, Naspro R, Gallina A, Salonia A, Vavassori I, Hurle R, et al. Impact on sexual function of holmium laser enucleation versus transurethral resection of the prostate: results of a prospective, 2-center, randomized trial. J Urol. 2006. 175:1817–1821.